Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Share-based Compensation (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Share-based Compensation readings, the most recent being $6.9 million for Q1 2026.

  • Quarterly Share-based Compensation rose 5.25% to $6.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $25.4 million through Mar 2026, up 16.38% year-over-year, with the annual reading at $25.0 million for FY2025, 23.87% up from the prior year.
  • Share-based Compensation hit $6.9 million in Q1 2026 for Oric Pharmaceuticals, up from $6.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $6.9 million in Q1 2026 and bottomed at $3.1 million in Q4 2022.
  • Average Share-based Compensation over 5 years is $4.8 million, with a median of $5.0 million recorded in 2024.
  • Peak annual rise in Share-based Compensation hit 43.77% in 2022, while the deepest fall reached 10.55% in 2022.
  • Oric Pharmaceuticals' Share-based Compensation stood at $3.1 million in 2022, then grew by 25.34% to $3.9 million in 2023, then skyrocketed by 32.63% to $5.2 million in 2024, then grew by 20.66% to $6.3 million in 2025, then increased by 9.88% to $6.9 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Share-based Compensation are $6.9 million (Q1 2026), $6.3 million (Q4 2025), and $5.6 million (Q3 2025).